Giovanni Frisoni
Nom du groupe: Laboratory of Neuroimaging of Aging
Affiliations: Faculty of Medicine, Geneva University Hospitals, Department of Psychiatry
Domaines: Development and Plasticity
Mot clés: Alzheimer's disease, biomarkers, health care
Activités de recherche
The group has over 20 years of experience in clinical and translational research on Alzheimer’s disease. The main scientific interest is the use of neuroimaging techniques and other biomarkers in persons with or at risk for cognitive impairment. Acquisitions and innovations in fundamental neurosciences, ICT, and technology are uptaken and translated for use into a clinical setting for better pathophysiological understanding, diagnosis, prognosis, disease tracking, drug therapy, and rehabilitation. Specific topics of investigation are: the clinical use of imaging and fluid biomarkers; in vivo neurobiology of Alzheimer’s disease; the clinical use of innovative PET ligands; harmonisation of imaging markers for clinical use; development of innovative image analysis environments based on advanced ICT technology.
Dernières publications
Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up.
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders.
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review.
Videos
Contact
Département de psychiatrie
HUG
Email: Giovanni.Frisoni@hcuge.ch